BioCentury
ARTICLE | Clinical News

Edaravone regulatory update

June 27, 2016 7:00 AM UTC

Mitsubishi submitted an NDA to FDA for edaravone to treat amyotrophic lateral sclerosis. The IV cerebral neuroprotectant and free radical scavenger is marketed in Japan and South Korea as Radicut for ...